Evidence map›Paper›PMID 36071894›Full record

ArticleFrontiers in neurology2022

Predicting progression to dementia with "comprehensive visual rating scale" and machine learning algorithms.

Chaeyoon Park, Jae-Won Jang, Gihun Joo, Yeshin Kim, Seongheon Kim, Gihwan Byeon, Sang Won Park, Payam Hosseinzadeh Kasani, Sujin Yum, Jung-Min Pyun and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Chaeyoon ParkDepartment of Convergence Security, Kangwon National University, Chuncheon, South Korea.
Jae-Won JangDepartment of Convergence Security, Kangwon National University, Chuncheon, South Korea.
Gihun JooInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Yeshin KimDepartment of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, South Korea.
Seongheon KimDepartment of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, South Korea.
Gihwan ByeonDepartment of Psychiatry, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, South Korea.
Sang Won ParkInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Payam Hosseinzadeh KasaniInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Sujin YumInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Jung-Min PyunDepartment of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, South Korea.
Young Ho ParkDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam, South Korea.
Jae-Sung LimDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Young Chul YounDepartment of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.
Hyun-Soo ChoiInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Chihyun ParkInterdisciplinary Graduate Program in Medical Bigdata Convergence, Chuncheon, South Korea.
Hyeonseung ImDepartment of Convergence Security, Kangwon National University, Chuncheon, South Korea.
SangYun KimDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam, South Korea.
Seoul National University · KRKangwon National University · KRKangwon National University Hospital · KRUlsan College · KRSoonchunhyang University Hospital Seoul · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Identifying biomarkers for predicting progression to dementia in patients with mild cognitive impairment (MCI) is crucial. To this end, the comprehensive visual rating scale (CVRS), which is based on magnetic resonance imaging (MRI), was developed for the assessment of structural changes in the brains of patients with MCI. This study aimed to investigate the use of the CVRS score for predicting dementia in patients with MCI over a 2-year follow-up period using various machine learning (ML) algorithms. Methods: We included 197 patients with MCI who were followed up more than once. The data used for this study were obtained from the Japanese-Alzheimer's Disease Neuroimaging Initiative study. We assessed all the patients using their CVRS scores, cortical thickness data, and clinical data to determine their progression to dementia during a follow-up period of over 2 years. ML algorithms, such as logistic regression, random forest (RF), XGBoost, and LightGBM, were applied to the combination of the dataset. Further, feature importance that contributed to the progression from MCI to dementia was analyzed to confirm the risk predictors among the various variables evaluated. Results: Of the 197 patients, 108 (54.8%) showed progression from MCI to dementia. Tree-based classifiers, such as XGBoost, LightGBM, and RF, achieved relatively high performance. In addition, the prediction models showed better performance when clinical data and CVRS score (accuracy 0.701-0.711) were used than when clinical data and cortical thickness (accuracy 0.650-0.685) were used. The features related to CVRS helped predict progression to dementia using the tree-based models compared to logistic regression. Conclusions: Tree-based ML algorithms can predict progression from MCI to dementia using baseline CVRS scores combined with clinical data.

Indexed as

Alzheimer's Diseasebrain MRImachine learningmild cognition impairmentvisual rating scale

Identifiers

PMID36071894
PMCPMC9443667
OpenAlexW4292634577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.